Intervention

irinotecan hydrochloride

ClinicalTrials.gov intervention label

Clinical trials37

Recruiting0

Common conditions25

Lead sponsors shown15

Clinical trials

37 shown

A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS MetastasesNCT01939483 · 2012-12-01

Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by SurgeryNCT00936832 · 2009-04-01

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or LungNCT00557102 · 2007-09-01

Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryNCT00616785 · 2007-06-01

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryNCT00513266 · 2007-06-01

Irinotecan and Cetuximab in Treating Patients With Metastatic Breast CancerNCT00275041 · 2006-02-01

Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain MetastasesNCT00617539 · 2005-02-01

Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung CancerNCT00118235 · 2004-12-01

Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung CancerNCT00182806 · 2004-09-01

Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast CancerNCT00303992 · 2004-05-01

Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung CancerNCT00132054 · 2004-05-01

Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast CancerNCT00079118 · 2004-04-01

Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung CancerNCT00449020 · 2004-01-01

Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerNCT00469898 · 2003-12-01

Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerNCT00072527 · 2003-11-01

Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerNCT00073866 · 2003-06-01

Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung CancerNCT00104793 · 2003-06-01

Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung CancerNCT00052494 · 2003-04-01

Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerNCT00059761 · 2003-03-01

Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung CancerNCT00062322 · 2003-02-01

S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung CancerNCT00045162 · 2002-11-01

Irinotecan and Capecitabine in Treating Women With Advanced Breast CancerNCT00083148 · 2002-11-01

UCN-01 and Irinotecan in Treating Patients With Advanced Solid TumorsNCT00047242 · 2002-08-01

Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerNCT00045604 · 2002-07-01

S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerNCT00030433 · 2002-01-01

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)NCT00031681 · 2001-12-01

Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00025285 · 2001-11-01

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung CancerNCT00005972 · 2000-05-01

Irinotecan in Treating Patients With Metastatic or Recurrent Breast CancerNCT00004182 · 1999-10-01

Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung CancerNCT00003900 · 1999-10-01

Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerNCT00004139 · 1999-09-01

Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsNCT00004095 · 1999-08-01

Irinotecan and Capecitabine in Treating Patients With Solid TumorsNCT00003867 · 1999-03-01

Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung CancerNCT00004924 · 1999-03-01

Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerNCT00022308 · 1999-01-01

Irinotecan in Treating Patients With Refractory Metastatic Breast CancerNCT00003351 · 1998-08-01

Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung CancerNCT00003111 · 1997-04-01

Common conditions

Leading sponsors

Alliance for Clinical Trials in Oncology7 Northwestern University3 Fox Chase Cancer Center2 Japan Multinational Trial Organization2 National Cancer Institute (NCI)2 Roswell Park Cancer Institute2 SWOG Cancer Research Network2 University of California, San Francisco2 Yale University2 Centre Hospitalier Universitaire Vaudois1 Federation Francophone de Cancerologie Digestive1 Memorial Sloan Kettering Cancer Center1 Montefiore Medical Center1 National Cancer Institute, France1 Radiation Therapy Oncology Group1

Trial status mix

COMPLETED33

UNKNOWN2

WITHDRAWN2

Phase mix

PHASE224

PHASE112

NA1

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.